Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection
about
Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral ResponsesHuman Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesCould vaccination with AIDSVAX immunogens have resulted in antibody-dependent enhancement of HIV infection in human subjects?Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDSEffect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.Human immunodeficiency virus antibodies and the vaccine problem.The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.H7N9 influenza: something old, something new ….Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection.Evidence for Complex Formation of the Bacillus cereus Haemolysin BL Components in Solution.Functions of Antibodies.Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.Non-Neutralizing Antibodies Directed against HIV and Their Functions.Applications of the FIV Model to Study HIV Pathogenesis.FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
P2860
Q25708015-5BAC7E46-487C-42E7-9DCD-E0850257AF15Q27318508-B49B0A6B-712B-4646-95FD-8B4E61210F10Q33723429-861C1930-A288-4A9C-AE0C-D386531332DEQ33867299-427180F7-2E9B-436C-B1FE-2EAD57D0D569Q33874253-1A9BE3DF-0BAB-46A0-A45D-A691068B1C97Q35097510-9B7DBEA8-869E-43DC-9902-01D11F6505A0Q36506821-BF789563-478C-4D7A-BE48-8741927932BEQ37528015-5E8C9C4B-17F8-4003-9465-A164206526F3Q38192126-CB9B55EA-99FF-496A-AA42-5D2EEDC7F764Q38994574-8F7B2C73-E799-4213-BAD4-CEB3294BAE99Q40239323-99B58183-EBC9-486D-AAB8-36AA2F1ABED9Q41556124-CBC90EBA-09C2-47F2-9F11-8C75A4E14A2BQ41669190-5F801310-6098-46CE-96BD-4BFD786BA2EEQ41741684-018D2750-8153-4AC5-951E-B30C37AF2DADQ47110966-7D46744A-7175-4CBD-A765-D87330BED90CQ47139556-C2F5FF4D-C752-475E-A3B5-B7D5692D7C8BQ52574472-1CE11D40-2BFF-405D-A0AE-018A0DC46C55Q53686365-DD5ADEA9-C91C-4D8B-B8B0-29201B9827B7Q54217627-5740B567-9D5E-4062-8F64-472E70A4FCE0
P2860
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Extensive complement-dependent ...... s at early stages of infection
@ast
Extensive complement-dependent ...... s at early stages of infection
@en
Extensive complement-dependent ...... s at early stages of infection
@en-gb
Extensive complement-dependent ...... s at early stages of infection
@nl
type
label
Extensive complement-dependent ...... s at early stages of infection
@ast
Extensive complement-dependent ...... s at early stages of infection
@en
Extensive complement-dependent ...... s at early stages of infection
@en-gb
Extensive complement-dependent ...... s at early stages of infection
@nl
prefLabel
Extensive complement-dependent ...... s at early stages of infection
@ast
Extensive complement-dependent ...... s at early stages of infection
@en
Extensive complement-dependent ...... s at early stages of infection
@en-gb
Extensive complement-dependent ...... s at early stages of infection
@nl
P2093
P2860
P3181
P356
P1433
P1476
Extensive complement-dependent ...... s at early stages of infection
@en
P2093
Ian Williams
Marlén M I Aasa-Chapman
Pierre Pellegrino
Robin A Weiss
Stephen O'Farrell
Suzanne Willey
P2860
P2888
P3181
P356
10.1186/1742-4690-8-16
P407
P50
P577
2011-03-14T00:00:00Z
P5875
P6179
1013156559